26-JUL-2024 6:10

MMYEL ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1803-MM, Maintenance, Len vs Len/Dara 1 Y 0 Screening 1420 1289 148 126 68 14 3 08/13/2019 326 127
            1289 148 126 68 14 3      
 
    2 Y 1 Lenalidomide   594 69 57 36 7 2 08/13/2019    
        2 Lenalidomide + Daratumumab   586 72 64 33 7 1      
            1180 141 121 69 14 3      
 
    3 Y 3 Stop vs Continue Treatment   194 80 31 15 6 0 08/13/2019    
            194 80 31 15 6 0      
 
  S2005-WM, Prev. Untreated, I/R +/- Venetoclax 1 Y 1 I+R 92 1 1 1 0 0 0 01/05/2022 71 25
        2 I+R+Venetoclax   1 0 0 0 0 0      
        3 V+R   3 3 3 3 1 0      
            5 4 4 3 1 0      
 
  S2209-MM, Newly Dx, VRd-R->R v DRd-R->R v DRD-DR->D 1 Y 1 VRD-R 510 10 10 6 3 1 0 10/12/2023 194 71
        2 DRD-R   11 11 7 4 2 0      
        3 DRD-DR   9 9 6 3 0 0      
            30 30 19 10 3 0      
 
  S2213-AL Amyloidosis, Newly Dx, Dara-VCD v ASCT 1 Y 0 Induction 338 1 1 1 1 1 0 07/01/2024 80 29
            1 1 1 1 1 0      
 
Yes EAA181-Myel, Newly Dx, DRd=>DRd+/-Btz=>DR (EQUATE) 0 E Total Registrations   46 15 2 0 0 0 05/27/2021 206 81
            46 15 2 0 0 0      
 
    1 E Total Registrations   35 12 3 0 0 0 05/27/2021    
            35 12 3 0 0 0      
 
    2 E Total Registrations   22 13 7 5 1 0 05/27/2021    
            22 13 7 5 1 0      
 
No EAA173-MYEL, SMM, Rd +/- Daratumumab 0 E Total Registrations   70 18 12 7 2 0 01/08/2020 235 98
            70 18 12 7 2 0      
 
    1 E Total Registrations   32 9 6 5 0 0 01/08/2020    
            32 9 6 5 0 0      
 

26-JUL-2024 6:10

MMYEL Open Studies with No Registrations

Study Registration/Phase Open Date # of
ACT.
INSTs		 # of
CURR
IRBs
S2213 AL Amyloidosis, Newly Dx, Dara-VCD v ASCT 2 Randomization 01-Dec-23 80 29
  3 Maintenance 01-Dec-23 80 29